DSM Biomedical and Cerapedics partner for peptide enhanced bone graft

DSM Biomedical has partnered with Cerapedics to create and manufacture the next generation of peptide-enhanced bone graft. The partnerships allows for DSM’s regenerative materials capabilities to be used with Cerapedics’s proprietary synthetic small peptide (P-15) technology. Designed for fast and predictable remodeling in bone graft substitute applications, DSM’s newest bioceramic platform is make of a